Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.
Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.
I heard this cancer therapy installs 5G tracking chips so the Clintons can listen to your conversations. Ha! Nice try libs! Too bad conservatives are too smart to fall for it!
we’ll die of preventable and curable illnesses to own the libs
@PrefersAwkward @Burn_The_Right
Ofc you will 'cause that’s what Jesus would have done.